Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism.

× No keyword cloud information.

19 in total

1. Placebo-controlled study of the effects of fingolimod on cardiac rate and rhythm and pulmonary function in healthy volunteers.

Authors: Robert Schmouder; Sam Hariry; Olivier J David
Journal: Eur J Clin Pharmacol Date: 2011-11-10 Impact factor: 2.953

2. Prolonged and symptomatic bradycardia following a single dose of fingolimod.

Authors: Hans Faber; Hans-Jörg Fischer; Frank Weber
Journal: Mult Scler Date: 2012-06-22 Impact factor: 6.312

3. Oral fingolimod (FTY720) for relapsing multiple sclerosis.

Authors: Ludwig Kappos; Jack Antel; Giancarlo Comi; Xavier Montalban; Paul O'Connor; Chris H Polman; Tomas Haas; Alexander A Korn; Goeril Karlsson; Ernst W Radue
Journal: N Engl J Med Date: 2006-09-14 Impact factor: 91.245

4. Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors: Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal: Ann Neurol Date: 2010-11-12 Impact factor: 10.422

5. Fingolimod and cardiac risk: latest findings and clinical implications.

Authors: Wendy S Vargas; Jai S Perumal
Journal: Ther Adv Drug Saf Date: 2013-06

Review 6. Sphingosine-1-phosphate signaling in the cardiovascular system.

Authors: Stephan L M Peters; Astrid E Alewijnse
Journal: Curr Opin Pharmacol Date: 2007-02-05 Impact factor: 5.547

Review 7. Sphingolipid signalling in the cardiovascular system: good, bad or both?

Authors: Astrid E Alewijnse; Stephan L M Peters
Journal: Eur J Pharmacol Date: 2008-03-15 Impact factor: 4.432

Review 8. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.

Authors: Volker Brinkmann
Journal: Br J Pharmacol Date: 2009-10-08 Impact factor: 8.739

9. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.

Authors: S Suzuki; S Enosawa; T Kakefuda; T Shinomiya; M Amari; S Naoe; Y Hoshino; K Chiba
Journal: Transplantation Date: 1996-01-27 Impact factor: 4.939

10. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.

Authors: Ulrich Hofmann; Natalie Burkard; Carolin Vogt; Annemarie Thoma; Stefan Frantz; Georg Ertl; Oliver Ritter; Andreas Bonz
Journal: Cardiovasc Res Date: 2009-05-05 Impact factor: 10.787